RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+21.75%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.87B
AUM Growth
+$435M
(+13%)
Cap. Flow
+$137M
Cap. Flow
% of AUM
3.53%
Top 10 Holdings %
Top 10 Hldgs %
35.18%
Holding
134
New
3
Increased
60
Reduced
11
Closed
5
Top Buys
| 1 |
Immunocore
IMCR
|
$38.6M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$36.8M |
| 3 |
Akero Therapeutics
AKRO
|
$23.5M |
| 4 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$20.7M |
| 5 |
Gossamer Bio
GOSS
|
$19M |
Top Sells
Sector Composition
| 1 | Healthcare | 96.8% |
| 2 | Consumer Staples | 0.91% |
| 3 | Industrials | 0.67% |
| 4 | Financials | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Akero Therapeutics
AKRO
$3.65B
| $46.6M | 1.2% |
1,369,973
+690,459
| +102% | +$23.5M |
|
|
HZNP
27
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $45M | 1.16% |
727,000
-19,000
| -3% | -$1.18M |
|
28
West Pharmaceutical
WST
$17.9B
| $44.4M | 1.15% |
180,500
+69,500
| +63% | +$17.1M |
|
29
Ascendis Pharma
ASND
$12.1B
| $43.9M | 1.13% |
425,500
| – | – |
|
30
Rhythm Pharmaceuticals
RYTM
$6.75B
| $43.1M | 1.11% |
1,760,865
+357,567
| +25% | +$8.76M |
|
31
Xenon Pharmaceuticals
XENE
$2.99B
| $41.7M | 1.08% |
1,155,961
+32,357
| +3% | +$1.17M |
|
32
Prothena Corp
PRTA
$452M
| $41.1M | 1.06% |
678,462
| – | – |
|
33
Zai Lab
ZLAB
$3.48B
| $40.8M | 1.05% |
1,192,400
-23,500
| -2% | -$804K |
|
34
Baxter International
BAX
$12.1B
| $40.7M | 1.05% |
755,500
+53,900
| +8% | +$2.9M |
|
|
CINC
35
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $39.6M | 1.02% |
1,205,856
+184,697
| +18% | +$6.06M |
|
36
DexCom
DXCM
$30.9B
| $39.5M | 1.02% |
490,500
+17,700
| +4% | +$1.43M |
|
|
RXDX
37
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $38.1M | 0.98% |
645,407
+900
| +0.1% | +$53.1K |
|
38
Mirum Pharmaceuticals
MIRM
$3.75B
| $37.7M | 0.97% |
1,795,733
+78,000
| +5% | +$1.64M |
|
|
SGEN
39
DELISTED
Seagen Inc. Common Stock
SGEN
| $37.2M | 0.96% |
272,000
| – | – |
|
40
iRhythm Technologies
IRTC
$5.67B
| $36.7M | 0.95% |
293,250
+23,250
| +9% | +$2.91M |
|
|
NVRO
41
DELISTED
NEVRO CORP.
NVRO
| $36.7M | 0.95% |
787,000
+13,700
| +2% | +$638K |
|
42
Freshpet
FRPT
$2.59B
| $35.1M | 0.91% |
700,000
+62,400
| +10% | +$3.13M |
|
|
CVET
43
DELISTED
Covetrus, Inc. Common Stock
CVET
| $35.1M | 0.91% |
1,678,800
| – | – |
|
44
Phreesia
PHR
$1.81B
| $33.2M | 0.86% |
1,302,500
+4,300
| +0.3% | +$110K |
|
|
ABCM
45
DELISTED
Abcam plc American Depositary Shares
ABCM
| $30.5M | 0.79% |
2,032,500
+412,000
| +25% | +$6.18M |
|
46
Mersana Therapeutics
MRSN
$34.8M
| $27.6M | 0.71% |
163,038
| – | – |
|
|
ACCD
47
DELISTED
Accolade, Inc. Common Stock
ACCD
| $26M | 0.67% |
2,274,000
+74,000
| +3% | +$845K |
|
48
Health Care Select Sector SPDR Fund
XLV
$33.8B
| $24.2M | 0.63% |
200,000
| – | – |
|
49
Travere Therapeutics
TVTX
$1.75B
| $23.4M | 0.61% |
951,650
| – | – |
|
50
Kymera Therapeutics
KYMR
$3.1B
| $22.8M | 0.59% |
1,046,743
+270,864
| +35% | +$5.9M |
|